SLU-PP-332 supports a shift toward greater energy utilization and metabolic efficiency, making it highly relevant for studies targeting obesity, metabolic syndrome, and weight loss
This early preclinical report demonstrates proof-of-principle that NMDAR antagonists may represent a new class of antidepressants
Compared with wild-type roots with nodules, PR1 and PR10 expression was markedly increased in untreated sym33-3 roots with nodules
No published randomized, controlled clinical trial has evaluated BPC-157 - including ProHealth's specific formulation - for any human health indication
Three years of competitive half-marathons had taken their toll on my left Achilles
They are very popular in Sri Lanka due to false marketing," Dr Weerasuriya, former CEO of the national medicines regulatory authority in Sri Lanka, told the ABC